ESSEX BIO-TECH 01061·

Gross margin 85.23%--90.26%5.03%89.93%0.33%89.75%0.18%89.20%0.55% Net margin 21.13%--17.11%4.02%15.85%1.26%18.40%2.55%17.54%0.86% ROE 19.95%--13.02%6.93%14.31%1.29%14.47%0.16%13.18%1.28% ROA 12.08%--8.31%3.77%9.73%1.42%10.30%0.56%9.11%1.19% Revenue growth -----12.09%--33.73%45.82%-1.76%35.49%5.95%7.71% Attributable profit growth -----28.82%--23.88%52.70%14.05%9.83%0.99%13.07% Debt-to-assets 39.43%--36.17%3.27%31.96%4.21%28.81%3.16%30.87%2.07% Current ratio 2.24--2.160.081.540.631.810.272.110.30 Operating cash flow / net profit 1.18--1.700.521.230.471.200.030.960.24 Operating cash flow / revenue 24.98%--29.05%4.06%19.53%9.52%22.07%2.54%16.89%5.18%

Gross margin 88.83%--83.63%5.19% Net margin 18.64%--14.11%4.53% Revenue growth -----10.48%-- Attributable profit growth -----32.24%-- Debt-to-assets ----29.50%-- Current ratio ----2.15-- Operating cash flow / net profit 0.75--0.890.14 Operating cash flow / revenue 13.97%--12.58%1.40%

Revenue 1.34B--1.18B12.09%1.57B33.73%1.55B1.76%1.64B5.95% Other income and gains -1.94M---2.80M44.05%23.38M936.05%31.45M34.51%10.98M65.07% Gross profit 1.14B--1.06B6.90%1.42B33.24%1.39B1.96%1.46B5.30% Selling and distribution expenses 683.48M--677.29M0.91%917.09M35.41%865.09M5.67%888.93M2.76% Administrative expenses 125.71M--139.33M10.83%196.62M41.12%198.12M0.76%201.62M1.77% Net finance costs 7.54M--10.25M35.88%10.16M0.85%5.64M44.52%7.06M25.22% Income tax 39.64M--31.20M21.29%64.12M105.49%63.23M1.39%87.22M37.95% Operating profit 330.05M--242.98M26.38%325.21M33.85%356.06M9.49%381.74M7.21% Share of associates and JVs -----173.14K---1.49M759.12%-2.70M81.23%-146.67K94.56% Profit before tax 322.51M--232.56M27.89%313.57M34.83%347.73M10.90%374.53M7.71% Net profit 282.86M--201.35M28.82%249.45M23.88%284.50M14.05%287.31M0.99% Net profit attributable to owners 282.86M--201.35M28.82%249.45M23.88%284.50M14.05%287.31M0.99%

Revenue 876.53M--784.69M10.48% Other income and gains -691.00K--19.73M2955.57% Cost of sales 97.93M--128.43M31.15% Gross profit 778.60M--656.26M15.71% Selling and distribution expenses 471.64M--396.52M15.93% Administrative expenses 99.74M--126.88M27.21% Net finance costs 2.80M--4.63M65.32% Income tax 40.17M--37.25M7.28% Share of associates and JVs -161.00K--0100.00% Profit before tax 203.57M--147.97M27.31% Net profit 163.40M--110.72M32.24% Net profit attributable to owners 163.40M--110.72M32.24%

Cash and cash equivalents 548.88M--485.48M11.55%462.03M4.83%515.96M11.67%706.98M37.02% Trade and bills receivables 551.28M--423.17M23.24%539.58M27.51%542.93M0.62%623.82M14.90% Inventories 79.78M--74.73M6.33%56.93M23.82%54.58M4.13%71.71M31.39% Total current assets 1.27B--1.08B14.29%1.13B4.07%1.19B5.31%1.46B23.14% Total assets 2.34B--2.42B3.49%2.56B5.76%2.76B7.81%3.15B14.14% Total current liabilities 563.81M--501.05M11.13%734.71M46.63%656.54M10.64%692.68M5.50% Total liabilities 923.20M--876.32M5.08%819.02M6.54%795.77M2.84%973.38M22.32% Equity attributable to owners 1.42B--1.55B9.07%1.74B12.72%1.97B12.81%2.18B10.83% Total equity 1.42B--1.55B9.07%1.74B12.72%1.97B12.81%2.18B10.83%

Cash and cash equivalents ----806.63M-- Trade and bills receivables ----722.23M-- Inventories ----87.04M-- Total current assets ----1.69B-- Total assets ----3.62B-- Total current liabilities ----784.08M-- Total liabilities ----1.07B-- Equity attributable to owners ----2.55B-- Total equity ----2.55B--

Net cash from operating activities 334.53M--341.93M2.21%307.39M10.10%341.22M11.00%276.67M18.92% Net cash from investing activities -229.00M---269.79M17.82%-49.24M81.75%-98.71M100.45%-149.19M51.14% Net cash from financing activities -59.79M---151.06M152.64%-280.86M85.92%-185.96M33.79%56.09M130.16% Net change in cash 45.74M---78.93M272.55%-22.71M71.23%56.55M349.03%183.57M224.63%

Net cash from operating activities 122.49M--98.68M19.43% Net cash from investing activities -111.10M---35.15M68.36% Net cash from financing activities 58.97M---59.83M201.46% Net change in cash 70.35M--3.71M94.73%